EML4-ALK positive lung adenocarcinoma with skeletal muscle metastasis in the right calf which was treatable with lorlatinib after resistance to treatment with alectinib

This report concerns a patient with skeletal muscle metastases due to lung adenocarcinoma harbouring an echinoderm microtubule-associated protein-like-4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangement, who was successfully treated with lorlatinib after resistance to alectinib. A right lower lo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Case Rep
Autors principals: Matsuda, Hironari, Hara, Munechika, Iwakami, Shin-Ichiro, Takahashi, Kazuhisa
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2021
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088238/
https://ncbi.nlm.nih.gov/pubmed/33906872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-240295
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars